 - Patient requires treatment with immunomodulating agents, such as systemic corticosteroids, interleukins, or interferons within 4 weeks prior to study entry, or patients who have received an HIV immunotherapeutic vaccine within 3 months prior to entry. Asthmatic patients using inhaled corticosteroids are eligible for enrollment. 